Recent studies revealed that upregulation of FOXQ1 was associated with progression of many human tumors, including those found in hepatocellular carcinoma [13], gastric cancer [14], colorectal carcinoma [15], prostate cancer [16], lung cancer [17], laryngeal carcinoma [18], esophageal cancer [19], pancreatic cancer [20], breast cancer [21], and BCa [22]. This evidence concerns the gene FOXQ1 and gastric cancer.